Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 16982548)

1.

Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.

Andratschke NH, Nieder C, Heppt F, Molls M, Zimmermann F.

Radiat Oncol. 2015 Mar 20;10:69. doi: 10.1186/s13014-015-0369-9.

2.

Recent advances in multidisciplinary management of hepatocellular carcinoma.

Gomaa AI, Waked I.

World J Hepatol. 2015 Apr 8;7(4):673-87. doi: 10.4254/wjh.v7.i4.673. Review.

3.
4.

Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.

Velec M, Moseley JL, Dawson LA, Brock KK.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1121-8. doi: 10.1016/j.ijrobp.2014.04.051. Epub 2014 Jul 8.

PMID:
25035217
5.

Stereotactic body radiation therapy for liver metastases.

Scorsetti M, Clerici E, Comito T.

J Gastrointest Oncol. 2014 Jun;5(3):190-7. doi: 10.3978/j.issn.2078-6891.2014.039. Review.

6.

The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities.

Que JY, Lin LC, Lin KL, Lin CH, Lin YW, Yang CC.

Radiat Oncol. 2014 May 28;9:120. doi: 10.1186/1748-717X-9-120.

7.

Stereotactic ablative radiotherapy for oligometastatic disease in liver.

Kim M, Son SH, Won YK, Kay CS.

Biomed Res Int. 2014;2014:340478. doi: 10.1155/2014/340478. Epub 2014 Apr 29. Review.

8.

Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.

Takeda A, Sanuki N, Kunieda E.

World J Gastroenterol. 2014 Apr 21;20(15):4220-9. doi: 10.3748/wjg.v20.i15.4220. Review.

9.

Treatment of metastatic liver tumors using stereotactic ablative radiotherapy.

Nair VJ, Pantarotto JR.

World J Radiol. 2014 Feb 28;6(2):18-25. doi: 10.4329/wjr.v6.i2.18. Review.

10.

Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.

Boda-Heggemann J, Frauenfeld A, Weiss C, Simeonova A, Neumaier C, Siebenlist K, Attenberger U, Heußel CP, Schneider F, Wenz F, Lohr F.

Radiat Oncol. 2014 Jan 8;9:10. doi: 10.1186/1748-717X-9-10.

11.

Stereotactic body radiation therapy for primary and metastatic liver tumors.

Liu E, Stenmark MH, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS, Feng M.

Transl Oncol. 2013 Aug 1;6(4):442-6. Print 2013 Aug.

12.

Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial.

Deodato F, Cilla S, Macchia G, Caravatta L, Mignogna S, Massaccesi M, Picardi V, Digesu C, Sallustio G, Bonomo P, Piermattei A, Ferrandina G, Scambia G, Valentini V, Cellini N, Morganti AG.

Oncol Lett. 2013 Jun;5(6):1889-1896. Epub 2013 Mar 29.

13.

Determination and comparison of radiotherapy dose responses for hepatocellular carcinoma and metastatic colorectal liver tumours.

Lausch A, Sinclair K, Lock M, Fisher B, Jensen N, Gaede S, Chen J, Wong E.

Br J Radiol. 2013 Jul;86(1027):20130147. doi: 10.1259/bjr.20130147. Epub 2013 May 20.

14.

Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors.

Kress MA, Collins BT, Collins SP, Dritschilo A, Gagnon G, Unger K.

Radiat Oncol. 2012 Sep 5;7:148. doi: 10.1186/1748-717X-7-148.

15.

Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.

Almaghrabi MY, Supiot S, Paris F, Mahé MA, Rio E.

Radiat Oncol. 2012 Aug 1;7:126. doi: 10.1186/1748-717X-7-126. Review.

16.

Single-fraction image-guided extracranial radiosurgery for recurrent and metastatic abdominal and pelvic cancers: short-term local control, metabolic response, and toxicity.

Perkins CL, El-Reyes B, Simon E, Kooby D, Torres W, Kauh JS, Staley CA, Landry JC.

J Gastrointest Oncol. 2010 Sep;1(1):16-23. doi: 10.3978/j.issn.2078-6891.2010.010.

17.

Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors.

Lanciano R, Lamond J, Yang J, Feng J, Arrigo S, Good M, Brady L.

Front Oncol. 2012 Mar 9;2:23. doi: 10.3389/fonc.2012.00023. eCollection 2012.

18.

Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.

Kuo YC, Chiu YM, Shih WP, Yu HW, Chen CW, Wong PF, Lin WC, Hwang JJ.

Radiat Oncol. 2011 Jun 21;6:76. doi: 10.1186/1748-717X-6-76.

19.

Radiotherapeutic Options for Symptom Control in Breast Cancer.

van Oorschot B, Beckmann G, Schulze W, Rades D, Feyer P.

Breast Care (Basel). 2011;6(1):14-19. Epub 2011 Feb 14.

20.

A survey of stereotactic body radiotherapy use in the United States.

Pan H, Simpson DR, Mell LK, Mundt AJ, Lawson JD.

Cancer. 2011 Oct 1;117(19):4566-72. doi: 10.1002/cncr.26067. Epub 2011 Mar 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk